The role of akt activation in the response to chemotherapy in pancreatic cancer

Colin M. Parsons, Diego Muilenburg, Tawnya L. Bowles, Subbulakshmi Virudachalam, Richard J Bold

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The PI3K/Akt signaling pathway is constitutively activated in some pancreatic cancers; when activated, it inhibits chemotherapy-mediated apoptosis. We examined whether Akt activity correlates with apoptotic resistance to chemotherapy in pancreatic cancer. Materials and Methods: A panel of human pancreatic cancer cells was evaluated for basal Akt activity as well as response to three chemotherapies. Chemotherapy-induced cell death was evaluated following either up- or down-regulation of Akt activity. Evaluation of phosphorylation of p21Cip/Waf1, a downstream target of Akt, was also evaluated. Results: There was a broad distribution among pancreatic cancer cell lines by Akt activity, as well as sensitivity to the three chemotherapeutic agents with no apparent correlation. Phosphorylation of p21Cip/Waf1, but not change in total levels, correlated with the chemosensitizing effect of Akt inhibition to paclitaxel. Conclusions: Basal Akt activity does not appear to be a useful predictor for selection of pancreatic cancers in targeting Akt to broadly induce chemosensitivity.

Original languageEnglish (US)
Pages (from-to)3279-3289
Number of pages11
JournalAnticancer Research
Volume30
Issue number9
StatePublished - Sep 2010

Fingerprint

Pancreatic Neoplasms
Drug Therapy
Phosphorylation
Paclitaxel
Phosphatidylinositol 3-Kinases
Cell Death
Up-Regulation
Down-Regulation
Apoptosis
Cell Line

Keywords

  • Akt
  • Apoptosis
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Parsons, C. M., Muilenburg, D., Bowles, T. L., Virudachalam, S., & Bold, R. J. (2010). The role of akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Research, 30(9), 3279-3289.

The role of akt activation in the response to chemotherapy in pancreatic cancer. / Parsons, Colin M.; Muilenburg, Diego; Bowles, Tawnya L.; Virudachalam, Subbulakshmi; Bold, Richard J.

In: Anticancer Research, Vol. 30, No. 9, 09.2010, p. 3279-3289.

Research output: Contribution to journalArticle

Parsons, CM, Muilenburg, D, Bowles, TL, Virudachalam, S & Bold, RJ 2010, 'The role of akt activation in the response to chemotherapy in pancreatic cancer', Anticancer Research, vol. 30, no. 9, pp. 3279-3289.
Parsons CM, Muilenburg D, Bowles TL, Virudachalam S, Bold RJ. The role of akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Research. 2010 Sep;30(9):3279-3289.
Parsons, Colin M. ; Muilenburg, Diego ; Bowles, Tawnya L. ; Virudachalam, Subbulakshmi ; Bold, Richard J. / The role of akt activation in the response to chemotherapy in pancreatic cancer. In: Anticancer Research. 2010 ; Vol. 30, No. 9. pp. 3279-3289.
@article{732aa82d9d064ba8ba17533a63299ebd,
title = "The role of akt activation in the response to chemotherapy in pancreatic cancer",
abstract = "The PI3K/Akt signaling pathway is constitutively activated in some pancreatic cancers; when activated, it inhibits chemotherapy-mediated apoptosis. We examined whether Akt activity correlates with apoptotic resistance to chemotherapy in pancreatic cancer. Materials and Methods: A panel of human pancreatic cancer cells was evaluated for basal Akt activity as well as response to three chemotherapies. Chemotherapy-induced cell death was evaluated following either up- or down-regulation of Akt activity. Evaluation of phosphorylation of p21Cip/Waf1, a downstream target of Akt, was also evaluated. Results: There was a broad distribution among pancreatic cancer cell lines by Akt activity, as well as sensitivity to the three chemotherapeutic agents with no apparent correlation. Phosphorylation of p21Cip/Waf1, but not change in total levels, correlated with the chemosensitizing effect of Akt inhibition to paclitaxel. Conclusions: Basal Akt activity does not appear to be a useful predictor for selection of pancreatic cancers in targeting Akt to broadly induce chemosensitivity.",
keywords = "Akt, Apoptosis, Pancreatic cancer",
author = "Parsons, {Colin M.} and Diego Muilenburg and Bowles, {Tawnya L.} and Subbulakshmi Virudachalam and Bold, {Richard J}",
year = "2010",
month = "9",
language = "English (US)",
volume = "30",
pages = "3279--3289",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

TY - JOUR

T1 - The role of akt activation in the response to chemotherapy in pancreatic cancer

AU - Parsons, Colin M.

AU - Muilenburg, Diego

AU - Bowles, Tawnya L.

AU - Virudachalam, Subbulakshmi

AU - Bold, Richard J

PY - 2010/9

Y1 - 2010/9

N2 - The PI3K/Akt signaling pathway is constitutively activated in some pancreatic cancers; when activated, it inhibits chemotherapy-mediated apoptosis. We examined whether Akt activity correlates with apoptotic resistance to chemotherapy in pancreatic cancer. Materials and Methods: A panel of human pancreatic cancer cells was evaluated for basal Akt activity as well as response to three chemotherapies. Chemotherapy-induced cell death was evaluated following either up- or down-regulation of Akt activity. Evaluation of phosphorylation of p21Cip/Waf1, a downstream target of Akt, was also evaluated. Results: There was a broad distribution among pancreatic cancer cell lines by Akt activity, as well as sensitivity to the three chemotherapeutic agents with no apparent correlation. Phosphorylation of p21Cip/Waf1, but not change in total levels, correlated with the chemosensitizing effect of Akt inhibition to paclitaxel. Conclusions: Basal Akt activity does not appear to be a useful predictor for selection of pancreatic cancers in targeting Akt to broadly induce chemosensitivity.

AB - The PI3K/Akt signaling pathway is constitutively activated in some pancreatic cancers; when activated, it inhibits chemotherapy-mediated apoptosis. We examined whether Akt activity correlates with apoptotic resistance to chemotherapy in pancreatic cancer. Materials and Methods: A panel of human pancreatic cancer cells was evaluated for basal Akt activity as well as response to three chemotherapies. Chemotherapy-induced cell death was evaluated following either up- or down-regulation of Akt activity. Evaluation of phosphorylation of p21Cip/Waf1, a downstream target of Akt, was also evaluated. Results: There was a broad distribution among pancreatic cancer cell lines by Akt activity, as well as sensitivity to the three chemotherapeutic agents with no apparent correlation. Phosphorylation of p21Cip/Waf1, but not change in total levels, correlated with the chemosensitizing effect of Akt inhibition to paclitaxel. Conclusions: Basal Akt activity does not appear to be a useful predictor for selection of pancreatic cancers in targeting Akt to broadly induce chemosensitivity.

KW - Akt

KW - Apoptosis

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=77958578733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958578733&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 3279

EP - 3289

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -